This article is based on published research, peer-reviewed studies, and information sourced directly from NeoLife's official Scientific Advisory Board documentation. It is intended for informational purposes only and does not constitute medical advice.
Most supplement companies develop products first and find supporting research afterward. NeoLife built its product development model around independent scientific oversight from 1976 onward — nearly five decades before transparency and proof of bioavailability became mainstream consumer demands.
Dr. Arthur Furst (1914–2005) held a Bachelor of Arts in chemistry from UCLA (1937), a Master of Arts from Stanford (1940), and a PhD from Stanford (1948). He later received an honorary Doctor of Science in toxicology from the University of San Francisco — the institution that now recognizes him as the "Father of Modern Toxicology." He founded the Stanford Cancer Chemotherapy Laboratory and contributed to early oral chemotherapy drug development. Furst served as Senior Member of the NeoLife SAB for approximately 25 years.
"Internationally regarded as a pioneer in toxicology and cancer research, Dr. Arthur Furst founded the Stanford Cancer Chemotherapy Laboratory and served as Senior Member of the NeoLife Scientific Advisory Board for 25 years." — University of San Francisco / NeoLife SAB documentation
In remembrance of Furst's contributions, NeoLife partnered with the University of San Francisco to establish the Dr. Furst Undergraduate Scholarship Award in 1995. It has been awarded annually since then to promising students in science.
Purity means systematic screening for contaminants across raw materials and finished products. For Salmon Oil Plus, this means screening against more than 200 potential contaminants per batch. Potency means using ingredients at clinically relevant levels derived from whole-food sources rather than synthetic isolates. Proof means requiring support via published or peer-reviewed research rather than relying solely on in-house data or anecdotal evidence.
The most extensively documented area of SAB-connected research involves NeoLife's Carotenoid Complex. The landmark study, published in the American Journal of Clinical Nutrition in 1994 by SAB members Carughi and Hooper (PMID: 8147336), was the first to confirm serum uptake of multiple carotenoids from a whole-food supplement. USDA-affiliated research documented a 37% increase in immune capacity over 20 days, with enhancement of natural killer cell and lymphocyte activity — and demonstrated that the broad-spectrum mixed carotenoid formula produced greater immune benefits than beta-carotene supplementation alone.
SAB member Arianna Carughi has also presented research on omega-3 fatty acid supplementation and membrane fluidity at the Experimental Biology Meeting and the 11th International Conference on Bioactive Lipids. In 1998, NeoLife became founding sponsor of PhenHRIG — the Plant Phenolics and Human Health Research Interest Group — which continues to fund student research awards.
| Criteria | NeoLife SAB | Typical Supplement Brand |
|---|---|---|
| Independent scientific board | Yes — since 1976 | Rarely |
| Named members with verifiable credentials | Yes — 10 current members | Rarely |
| Peer-reviewed publications by board members | Yes — multiple journals | Rarely |
| Three-standard formulation framework | Yes — Purity, Potency, Proof | No standard framework |
| External research sponsorship | Yes — PhenHRIG since 1998 | Rarely |
| University scholarship program | Yes — USF since 1995 | No |
The SAB is an independent body of scientists established in 1976 to govern NeoLife product development on three standards: Purity, Potency, and Proof. It was founded by Dr. Arthur Furst, a Stanford-trained toxicologist and cancer researcher. The current board comprises ten members with expertise spanning nutrition science, biochemistry, exercise physiology, microbial biochemistry, food science, and sports nutrition.
SAB members have published in the American Journal of Clinical Nutrition (PMID: 8147336), Journal of the American College of Nutrition, Annals of the New York Academy of Sciences, and Free Radical Biology and Medicine. The most cited work involves Carotenoid Complex bioavailability and USDA-partnered immune function research.
PhenHRIG — the Plant Phenolics and Human Health Research Interest Group — is a research program that NeoLife founded and has sponsored since 1998. It supports scientific research into plant phenolics and human health, and awards annual student research prizes to emerging scientists.
Available through a two-tier pricing model.